Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Shanghai Stock Exchange 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Net Income for the year ending December 31, 2023: USD 145.53 M

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Net Income is USD 145.53 M for the year ending December 31, 2023, a 9.03% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Net Income for the year ending December 31, 2022 was USD 133.49 M, a 33.80% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Net Income for the year ending December 31, 2021 was USD 99.76 M, a 71.10% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Net Income for the year ending December 31, 2020 was USD 58.31 M, a 70.75% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Net Income for the year ending December 31, 2019 was USD 34.15 M, a 49.45% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Shanghai Stock Exchange: 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

CEO	Mr. Yi Jiang Mei
IPO Date	Oct. 10, 2014
Location	China
Headquarters	99 Waisha Road
Employees	4,877
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Key trends

Past 5 years